KANSAS CITY, Mo., June 29, 2021 /PRNewswire/ — CBD American Shaman, the nation’s largest brick and mortar CBD retailer with over 360 locations nationwide, released results of three studies supporting the use of CBD to provide relief from sleeplessness, assistance in management of pain, ADHD, IBS, and chronic fatigue, as well as the safe consumption of CBD citing no harmful effects on the liver.
All three studies released at The International Cannabinoid Research Society (ICRS) conference support CBD’s efficacy. The first study titled, “Use of a Water-Soluble Form of Cannabinol for the Treatment of Sleeplessness,” analyzed the use of nano treated water-soluble CBN, a compound of the hemp plant taken at a specific life stage, and its effect on sleeplessness. The study found that CBN significantly improved both the length and quality of sleep. It induced sleep faster, kept participants from waking during the evening, and overall improved sleep quality (enabling normal progression through the various stages of sleep) so individuals woke up feeling rested.
“The main thing these studies show is how dedicated we are to science,” said Vince Sanders, President and Founder of CBD American Shaman. “Acknowledgement by the top group in cannabinoid medicine is validation that our nano-treated CBD products work. It has taken years of hard work and the belief that the only way to learn more is through science, but it’s still an ongoing process to see what else we can do.”
The second study titled, “Nano Processed CBG/CBD: Effect on Pain, Attention Deficit and Hyperactivity Disorder, Irritable Bowel Syndrome, and Chronic Fatigue,” analyzed how a solution combining 5mg/ml CBD and 15mg/ml CBG improved chronic conditions for some individuals. The results indicated the CBG/CBD solution helped those suffering from pain and IBS symptoms, improved thinking and attention levels for those with ADHD, and improved energy levels for those with chronic fatigue.
The third and final study titled, “Observed Impact of Long-Term Consumption of Oral Cannabidioll on Liver Function of Healthy Adults,” analyzed how CBD impacts liver function with consumption. The study results found that CBD did not elevate liver function tests and did not result in liver failure, making it safe for consumption. Additionally, on average, individuals taking nano-treated CBD (in this instance from CBD American Shaman) used 7 times less CBD per day than those using non-nano treated CBD (7.6 mg versus 54.0 mg).
“The results from these studies are striking,” said Dr. Robert Kaufmann, primary author and designer of all three studies. “They demonstrate the safety of CBD, and specifically how little CBD is actually needed to produce significant effects when nano-treated CBD is used.”
The studies released explore just some of the potential ways cannabinoids can be utilized for effective assistance with specific ailments and chronic conditions. CBD American Shaman prioritizes education around CBD and other cannabinoids specially for medicinal and therapeutic purposes. For more information on CBD American Shaman, these studies, and CBD products, please visit https://cbdamericanshaman.com.
About American Shaman
Vince Sanders founded CBD American Shaman in 2014 in Kansas City, Missouri as a resource to help manage the discomfort cancer patients experience. Since then, Sanders has built CBD American Shaman into a team of doctors, chemists, lawyers, and advocates. Sanders pioneered the use of nanotechnology in the hemp industry to enhance the plant’s health-supporting effects and to increase the bioavailability of CBD.
CBD American Shaman produces high quality cannabinoid tinctures, creams, pet products and more. CBD American Shaman is certified by the US Hemp Authority for its manufacturing and quality control standards. Currently with 365 locations offering their premier CBD products, American Shaman is one of the largest CBD retailers in the United States.
SOURCE CBD American Shaman
CBD American Shaman Releases Studies Supporting Efficacy of CBD
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2021.
Use Cannin as your resource for:
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you looking to buy stock in hemp companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.